BNY Mellon U.S. Equity Income GBP Sterling W AccRegister to Unlock Ratings |
Performance History | 31/05/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 3.4 | 7.4 | |
+/-Cat | - | - | - | -0.1 | 1.5 | |
+/-B’mrk | - | - | - | 3.8 | -0.2 | |
Category: US Equity Income | ||||||
Category Benchmark: Morningstar US High Div Yld... |
Key Stats | ||
NAV 24/06/2024 | GBP 1.09 | |
Day Change | 0.61% | |
Morningstar Category™ | US Equity Income | |
IA (formerly IMA) Sector | North America | |
ISIN | IE00BD5M7445 | |
Fund Size (Mil) 31/05/2024 | USD 588.76 | |
Share Class Size (Mil) 24/06/2024 | GBP 0.27 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 16/11/2022 | 0.88% |
Investment Objective: BNY Mellon U.S. Equity Income GBP Sterling W Acc |
The Sub-Fund aims to maximise total returns from income and capital growth. The Sub-Fund invests primarily (meaning at least two-thirds of the Sub-Fund's Net Asset Value) in equity and equity-related securities (common and preferred stock, American depositary receipts and global depository receipts (collectively “Depositary Receipts”), listed real estate investment trusts (“REITs”) and master limited partnerships (“MLPs”)), issued by “large-capitalisation companies” located in the U.S. The term “large-capitalisation companies” shall be taken to include securities of companies which, at the time of purchase, have a market capitalisation of US$2 billion or above. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Bailer 17/01/2017 | ||
Brian Ferguson 17/01/2017 | ||
Click here to see others | ||
Inception Date 16/11/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | Morningstar US High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon U.S. Equity Income GBP Sterling W Acc | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
JPMorgan Chase & Co | Financial Services | 4.76 |
Medtronic PLC | Healthcare | 3.92 |
AT&T Inc | Communication Services | 3.75 |
Cisco Systems Inc | Technology | 3.24 |
Sanofi SA ADR | Healthcare | 3.15 |
Increase Decrease New since last portfolio | ||
BNY Mellon U.S. Equity Income GBP Sterling W Acc |